TORRANCE, Calif., Feb. 1 /PRNewswire/ -- Total Renal Care Holdings, Inc. (NYSE: TRL), the nation's second-largest provider of dialysis services, today announced the appointment of Douglas Vlchek as Vice President. Mr. Vlchek will assist in many areas surrounding operational improvement, but his initial role will be to spearhead the development and implementation of management development programs for all levels of the organization. Mr. Vlchek will work for Total Renal Care half time and will continue to be based in Denver, Colorado.
Mr. Vlchek has over thirty years experience in the dialysis industry, having most recently served as Vice President of Gambro Healthcare, and Vivra Renal Care, where he worked with Kent Thiry and David Barry, Total Renal Care's CEO and President, respectively. He has authored five books and over 200 articles in technical and clinical areas of dialysis as well as quality assurance and quality improvement. He has served on a variety of FDA and HCFA committees for health standards, education, and quality.
Thiry notes, "We are very excited to have Doug join our team. His vast knowledge and experience in dialysis was instrumental in the success we had at Vivra Renal Care; his teambuilding, teaching and facilitation talents will be a valuable addition to our efforts to achieve our Company's mission. Doug was one of the primary architects of Vivra University, a management development program which our administrators loved."
Total Renal Care Holdings, Inc., based in Torrance, California, is the second-largest provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 32 states, as well as Washington, D.C. It also provides acute hemodialysis services to inpatients at approximately 330 hospitals. As of December 1, 1999, Total Renal Care operated 488 outpatient dialysis facilities serving over 40,000 patients.
SOURCE Total Renal Care Holdings, Inc.
CONTACT: LeAnne Zumwalt, Investor Relations, of Total Renal Care, Inc., 310-792-2600, ext. 2449/